Abametapir: Side Effects, Uses & Monitoring
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.
- Data source
- FDA labeling via NIH DailyMed (label 4fe38e95…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. XEGLYZE should be used in the context of an overall lice management program: Wash (with hot water) or dry-clean all recently worn clothing, hats, used bedding and towels Wash personal care items such as combs, brushes, and hair clips in hot water Use a fine-tooth comb or special nit comb to remove dead lice and nits
Frequently Asked Questions
What is Abametapir used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Abametapir?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Abametapir require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Abametapir.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.